A&P, Wachtell Join Namenda Fight as Actavis Appeals Injunction

A&P, Wachtell Join Namenda Fight as Actavis Appeals Injunction

Scott Flaherty

Less than a week after a judge blocked Actavis from forcing patients to switch to new version of its Alzheimer's drug Namenda, the company brought on new legal firepower from Arnold & Porter and Wachtell, Lipton, Rosen & Katz to take the case to the Second Circuit.

      LOAD MORE